Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Corvus Pharmaceuticals, Inc. | a2231221zex-32_1.htm |
| EX-31.2 - EX-31.2 - Corvus Pharmaceuticals, Inc. | a2231221zex-31_2.htm |
| EX-31.1 - EX-31.1 - Corvus Pharmaceuticals, Inc. | a2231221zex-31_1.htm |
| EX-21.1 - EX-21.1 - Corvus Pharmaceuticals, Inc. | a2231221zex-21_1.htm |
| 10-K - 10-K - Corvus Pharmaceuticals, Inc. | a2231221z10-k.htm |
QuickLinks -- Click here to rapidly navigate through this document
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-210456) of Corvus Pharmaceuticals, Inc. of our report dated March 10, 2017 relating to the financial statements, which appear in this Form 10-K.
/s/
PricewaterhouseCoopers LLP
San Jose, CA
March 10, 2017
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM